Moderna and Merck shares soar on mRNA cancer vaccine

1 comments

• ChrisArchitect 8 hours ago

  Related:

  Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma

  https://news.ycombinator.com/item?id=49361395